Published in Lancet on March 31, 1984
Serum C reactive protein in infective endocarditis. J Clin Pathol (1988) 0.97
Comparison of cerebrospinal fluid C-reactive protein and lactate for diagnosis of meningitis. J Clin Microbiol (1986) 0.80
Serum C-reactive protein concentration in the management of infection in patients treated by continuous ambulatory peritoneal dialysis. J Clin Pathol (1985) 0.78
SEQAID: a DNA sequence assembling program based on a mathematical model. Nucleic Acids Res (1984) 6.91
Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J (2000) 4.87
Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics (1977) 4.64
Meningococcal disease: still with us. Rev Infect Dis (1983) 4.36
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med (1984) 3.37
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
Viruses and bacteria in the etiology of the common cold. J Clin Microbiol (1998) 3.24
Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol (2000) 3.02
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90
A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr (2007) 2.82
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med (1987) 2.47
Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis. J Clin Microbiol (1993) 2.41
Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet (1986) 2.34
Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet (1986) 2.21
Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 2.16
Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol (1999) 2.09
Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child (1991) 2.05
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet (1998) 2.01
Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol (1998) 1.89
Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza. BMJ (2001) 1.85
Measles history and atopic diseases: a population-based cross-sectional study. JAMA (2000) 1.81
Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children. J Clin Microbiol (1999) 1.75
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
Viruses and bacteria in sputum samples of children with community-acquired pneumonia. Clin Microbiol Infect (2011) 1.70
Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J Infect Dis (1981) 1.65
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics (1984) 1.65
Signs and symptoms predicting acute otitis media. Arch Pediatr Adolesc Med (1995) 1.64
Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J Clin Microbiol (1996) 1.64
Differentiation of bacterial and viral pneumonia in children. Thorax (2002) 1.59
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J (2000) 1.56
Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis (1982) 1.56
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52
Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime. Eur J Pediatr (2000) 1.51
Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J (2000) 1.50
Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child (1991) 1.49
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
The effect of a recent previous visit to a physician on outcome after childhood bacterial meningitis. JAMA (1994) 1.48
Effect of sport stress on lymphocyte transformation and antibody formation. Clin Exp Immunol (1978) 1.43
Trends in hospitalization for childhood asthma in Finland in 1996-2004. Acta Paediatr (2007) 1.42
Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. Bone Marrow Transplant (2013) 1.41
Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics (1994) 1.40
Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax (2008) 1.39
Intrafamilial spread of pertussis. J Pediatr (1983) 1.39
Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet (1991) 1.39
Measles vaccination after exposure to natural measles. J Pediatr (1978) 1.37
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Meningococcal disease in Scandinavia. Br Med J (Clin Res Ed) (1982) 1.35
Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine (2001) 1.34
Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics (1985) 1.34
Changes in erythrocyte sedimentation rate and C-reactive protein after total hip arthroplasty. Clin Orthop Relat Res (1984) 1.31
Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol (1997) 1.29
Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. J Clin Microbiol (1990) 1.29
Immunoassay diagnosis of adenovirus infections in children. J Clin Microbiol (1983) 1.29
Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J (1997) 1.28
Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay. J Med Virol (1984) 1.28
Diagnosis of respiratory syncytial virus infection in children: comparison of viral antigen detection and serology. J Med Virol (1984) 1.27
Risk factors for recurrent otitis media. Pediatr Infect Dis (1986) 1.26
C-reactive protein in rapid differentiation of acute epiglottitis from spasmodic croup and acute laryngotracheitis: a preliminary report. J Pediatr (1983) 1.25
Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group. J Infect Dis (1992) 1.22
Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet (1982) 1.21
Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J (1989) 1.20
Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis (1998) 1.20
Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol (2001) 1.19
Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis (1976) 1.19
Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician. Eur J Pediatr (1987) 1.19
Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis (1978) 1.19
Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia. Clin Microbiol Infect (2013) 1.19
Sinusitis in the common cold. J Allergy Clin Immunol (1998) 1.18
Report of a workshop on respiratory viral infections: epidemiology, diagnosis, treatment, and prevention. Clin Infect Dis (1993) 1.18
Trips to the South--a health hazard. Morbidity of Finnish travellers. Scand J Infect Dis (1983) 1.17
C-reactive protein in respiratory virus infections. J Pediatr (1985) 1.17
Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics (1998) 1.16
C reactive protein in the evaluation of febrile illness. Arch Dis Child (1986) 1.16
Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis (1993) 1.15
Molecular diagnosis of human rhinovirus infections: comparison with virus isolation. J Clin Microbiol (1998) 1.14
Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr Infect Dis J (1995) 1.14
Finnish approach to the treatment of acute otitis media. Report of the Finnish Consensus Conference. Ann Otol Rhinol Laryngol Suppl (1987) 1.13
Diagnosis of pertussis. J Infect (1984) 1.13
Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia. Clin Infect Dis (2001) 1.11
A new micromethod for lymphocyte stimulation using whole blood. Immunol Commun (1975) 1.11
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect (2000) 1.10
Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol (1998) 1.10
Fever in respiratory virus infections. Am J Dis Child (1986) 1.10
Clinical "pneumococcal pneumonia" due to Moraxella osloensis: case report and a review. Scand J Infect Dis (2001) 1.09
Fever, C-reactive protein, and erythrocyte sedimentation rate in monitoring recovery from septic arthritis: a preliminary study. J Pediatr Orthop (1984) 1.08
Staphylococcus aureus Cowan I-induced immunoglobulin production in human cord blood lymphocytes. J Immunol (1980) 1.08
C-reactive protein compared with white blood cell count and erythrocyte sedimentation rate in the diagnosis of acute appendicitis in children. Acta Chir Scand (1986) 1.06
Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. J Infect Dis (1987) 1.06
Bacteremic urinary tract infection in children. Pediatr Infect Dis J (2000) 1.06
Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J Infect Dis (1990) 1.05
Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J (1995) 1.05
Respiratory virus infections during anticancer treatment in children. Pediatr Infect Dis J (1995) 1.05
Rhinovirus in acute otitis media. J Pediatr (1988) 1.04
Temporal development of acute otitis media during upper respiratory tract infection. Pediatr Infect Dis J (1994) 1.04
Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide. J Pediatr (1978) 1.04